A Case of Mycobacterium gordonae Pulmonary Disease in a Patient with Ulcerative Colitis Treated with Infliximab / 대한내과학회지
Korean Journal of Medicine
;
: 452-456, 2015.
Article
in Korean
| WPRIM
| ID: wpr-153843
ABSTRACT
Tumor necrosis factor-alpha (TNF-alpha) is a key component of the host defense against mycobacterial infection. Mycobacterium gordonae (M. gordonae) is one of the least virulent mycobacteria, and is generally considered non-pathogenic if detected from a clinical specimen. Here, we report a rare case of pulmonary M. gordonae infection in a patient with ulcerative colitis who had been treated with infliximab, a TNF-alpha antagonist. M. gordonae infection was treated successfully with clarithromycin, rifampin, and ethambutol. We believe this to be the first report of M. gordonae pulmonary disease associated with TNF-alpha antagonist treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Rifampin
/
Ulcer
/
Colitis, Ulcerative
/
Tumor Necrosis Factor-alpha
/
Clarithromycin
/
Gordonia Bacterium
/
Ethambutol
/
Infliximab
/
Lung Diseases
/
Mycobacterium
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS